IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v22y2025i6p926-d1676926.html
   My bibliography  Save this article

Evaluating the Cost-Effectiveness of Air Pollution Mitigation Strategies: A Systematic Review

Author

Listed:
  • Bo Vandenbulcke

    (Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium
    Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, ON2 Herestraat 49, P.O. Box 521, 3000 Leuven, Belgium)

  • Nick Verhaeghe

    (Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium
    Department of Public Health and Primary Care, Interuniversity Centre for Health Economics Research (i-CHER), Ghent University, Corneel Heymanslaan 10, 9000 Ghent, Belgium)

  • Lisa Cruycke

    (Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium)

  • Max Lelie

    (Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium)

  • Steven Simoens

    (Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, ON2 Herestraat 49, P.O. Box 521, 3000 Leuven, Belgium
    These authors contributed equally to this work.)

  • Koen Putman

    (Department of Public Health, Interuniversity Centre for Health Economics Research (i-CHER), Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Jette, Belgium
    These authors contributed equally to this work.)

Abstract

Air pollution is the world’s greatest environmental health risk. Pollutants that pose large health concerns are particulate matter (PM 2.5 and PM 10 ), ozone (O 3 ), carbon monoxide (CO), nitrogen dioxide (NO 2 ), and sulphur dioxide (SO 2 ). These compounds (especially PM 2.5 and PM 10 ) contribute to the onset of diseases, such as respiratory diseases (e.g., asthma, chronic obstructive pulmonary disease (COPD), or lung cancer) and cardiovascular diseases. Abatement interventions are implemented to reduce air pollution and thereby the risk of these diseases. This systematic review examined the published scientific evidence on the cost-effectiveness of strategies aimed at reducing or controlling air pollution and assessed the reporting quality of included studies. It employed rigorous data extraction and quality scoring procedures to ensure the reliability and validity of our findings. Overall, there is substantial evidence supporting the cost-effectiveness of interventions aimed at reducing air pollution. Seventy-four studies and four policy reports were included in this review. Predominantly, cost–benefit analyses have been reported ( n = 40), reflecting the multisectoral impacts and associated costs of air pollution. Only four cost–utility analyses were found, indicating the need for more research within this domain. Additionally, eight articles reported one or more non-economic results. Thirty-nine studies focused on particulate matter (PM), and eleven focused on nitrogen oxides (NOx). The quality assessment yielded moderate results. The heterogeneity of studies and moderate quality of reporting make it difficult to compare results and draw definitive conclusions.

Suggested Citation

  • Bo Vandenbulcke & Nick Verhaeghe & Lisa Cruycke & Max Lelie & Steven Simoens & Koen Putman, 2025. "Evaluating the Cost-Effectiveness of Air Pollution Mitigation Strategies: A Systematic Review," IJERPH, MDPI, vol. 22(6), pages 1-37, June.
  • Handle: RePEc:gam:jijerp:v:22:y:2025:i:6:p:926-:d:1676926
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/22/6/926/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/22/6/926/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Jia Zhou & Hongqiang Jiang & Xi Cheng & Yaling Lu & Wei Zhang & Zhanfeng Dong, 2022. "Are the Benefits of a High-Emission Vehicle Driving Area Restriction Policy Greater than the Costs?," IJERPH, MDPI, vol. 19(23), pages 1-14, November.
    2. Zhang, Hui & Zhang, Bing & Bi, Jun, 2015. "More efforts, more benefits: Air pollutant control of coal-fired power plants in China," Energy, Elsevier, vol. 80(C), pages 1-9.
    3. David G T Whitehurst & Danielle N DeVries & Daniel Fuller & Meghan Winters, 2021. "An economic analysis of the health-related benefits associated with bicycle infrastructure investment in three Canadian cities," PLOS ONE, Public Library of Science, vol. 16(2), pages 1-16, February.
    4. Vinh Van Tran & Duckshin Park & Young-Chul Lee, 2020. "Indoor Air Pollution, Related Human Diseases, and Recent Trends in the Control and Improvement of Indoor Air Quality," IJERPH, MDPI, vol. 17(8), pages 1-27, April.
    5. Wagner, Susanne & Angenendt, Elisabeth & Beletskaya, Olga & Zeddies, Jürgen, 2017. "Assessing ammonia emission abatement measures in agriculture: Farmers' costs and society's benefits – A case study for Lower Saxony, Germany," Agricultural Systems, Elsevier, vol. 157(C), pages 70-80.
    6. Hamidreza Shamsi & Mohammad Munshed & Manh-Kien Tran & Youngwoo Lee & Sean Walker & Jesse The & Kaamran Raahemifar & Michael Fowler, 2021. "Health Cost Estimation of Traffic-Related Air Pollution and Assessing the Pollution Reduction Potential of Zero-Emission Vehicles in Toronto, Canada," Energies, MDPI, vol. 14(16), pages 1-21, August.
    7. Laura Bojke & Laetitia Schmitt & James Lomas & Gerry Richardson & Helen Weatherly, 2018. "Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments," IJERPH, MDPI, vol. 15(11), pages 1-9, November.
    8. Drummond, Michael F. & Sculpher, Mark J. & Claxton, Karl & Stoddart, Greg L. & Torrance, George W., 2015. "Methods for the Economic Evaluation of Health Care Programmes," OUP Catalogue, Oxford University Press, edition 4, number 9780199665884, Decembrie.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Irina Pokhilenko & Luca M. M. Janssen & Aggie T. G. Paulus & Ruben M. W. A. Drost & William Hollingworth & Joanna C. Thorn & Sian Noble & Judit Simon & Claudia Fischer & Susanne Mayer & Luis Salvador-, 2023. "Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 155-166, March.
    2. Chiranjeev Sanyal & Don Husereau, 2020. "Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 375-392, June.
    3. Yesim Tozan & Joshua Kiyingi & Sooyoung Kim & Flavia Namuwonge & Florence Namuli & Vicent Ssentumbwe & Rashida Namirembe & Edwinnah Kasidi & Ozge Sensoy Bahar & Mary M Mckay & Fred M Ssewamala, 2024. "Micro-costing analysis of a combination intervention for improved mental health and HIV risk behaviors among school-going adolescent girls in Uganda," PLOS Mental Health, Public Library of Science, vol. 1(7), pages 1-14, December.
    4. Dong-Won Kang & Patricio B. Lynn & Li Wang & Shouhao Zhou & Chan Shen, 2025. "Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA," PharmacoEconomics - Open, Springer, vol. 9(1), pages 93-101, January.
    5. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
    6. Valentina Prevolnik Rupel & Marko Ogorevc, 2023. "EQ-5D-5L Value Set for Slovenia," PharmacoEconomics, Springer, vol. 41(11), pages 1515-1524, November.
    7. Julie A. Campbell & Glen J. Henson & Valery Fuh Ngwa & Hasnat Ahmad & Bruce V. Taylor & Ingrid Mei & Andrew J. Palmer, 2025. "Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modif," PharmacoEconomics, Springer, vol. 43(2), pages 223-239, February.
    8. Christopher M Doran & Irina Kinchin, 2020. "Economic and epidemiological impact of youth suicide in countries with the highest human development index," PLOS ONE, Public Library of Science, vol. 15(5), pages 1-11, May.
    9. Boniface Oyugi & Olena Nizalova & Sally Kendall & Stephen Peckham, 2024. "Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(1), pages 77-89, February.
    10. Kaspar Walter Meili & Anna Månsdotter & Linda Richter Sundberg & Jan Hjelte & Lars Lindholm, 2022. "An initiative to develop capability-adjusted life years in Sweden (CALY-SWE): Selecting capabilities with a Delphi panel and developing the questionnaire," PLOS ONE, Public Library of Science, vol. 17(2), pages 1-21, February.
    11. Muchandifunga Trust Muchadeyi & Karla Hernandez-Villafuerte & Gian Luca Tanna & Rachel D. Eckford & Yan Feng & Michela Meregaglia & Tessa Peasgood & Stavros Petrou & Jasper Ubels & Michael Schlander, 2024. "Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations," PharmacoEconomics, Springer, vol. 42(7), pages 767-782, July.
    12. Lili Wang & Lei Si & Fiona Cocker & Andrew J. Palmer & Kristy Sanderson, 2018. "A Systematic Review of Cost-of-Illness Studies of Multimorbidity," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 15-29, February.
    13. Etienne Nédellec & Judith Pineau & Patrice Prognon & Nicolas Martelli, 2018. "Level of Evidence in Economic Evaluations of Left Atrial Appendage Closure Devices: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 793-802, December.
    14. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    15. Hensher, Martin & Canny, Ben & Zimitat, Craig & Campbell, Julie & Palmer, Andrew, 2020. "Health care, overconsumption and uneconomic growth: A conceptual framework," Social Science & Medicine, Elsevier, vol. 266(C).
    16. Dongzhe Hong & Lei Si & Minghuan Jiang & Hui Shao & Wai-kit Ming & Yingnan Zhao & Yan Li & Lizheng Shi, 2019. "Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review," PharmacoEconomics, Springer, vol. 37(6), pages 777-818, June.
    17. Werner Brouwer & Kaya Verbooy & Renske Hoefman & Job Exel, 2023. "Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects," PharmacoEconomics, Springer, vol. 41(9), pages 1103-1115, September.
    18. Yakubu Adole Agada-Amade & Daniel Chukwuemeka Ogbuabor & Eric Obikeze & Ejemai Eboreime & Obinna Emmanuel Onwujekwe, 2024. "Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria," Health Economics Review, Springer, vol. 14(1), pages 1-8, December.
    19. Simon Pol & Paula Rojas Garcia & Fernando Antoñanzas Villar & Maarten J. Postma & Antoinette D. I. Asselt, 2021. "Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting," PharmacoEconomics, Springer, vol. 39(12), pages 1355-1363, December.
    20. Paul Revill & Simon Walker & Valentina Cambiano & Andrew Phillips & Mark J Sculpher, 2018. "Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-13, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:22:y:2025:i:6:p:926-:d:1676926. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.